BMEZ

BlackRock Health Sciences Trust II
NYSEFINANCIAL SERVICESASSET MANAGEMENT

Key Statistics

Market Cap
$968.15M
P/E Ratio
6.10
EPS
$2.54
Beta
52W High
$15.66
52W Low
$12.40
50-Day MA
$14.82
200-Day MA
$14.81
Dividend Yield
0.00%
Profit Margin
0.00%
Forward P/E
PEG Ratio

About BlackRock Health Sciences Trust II

BlackRock Health Sciences Trust II (BMEZ) is a closed-end fund that focuses on delivering high total returns through a diversified portfolio primarily concentrated in the health sciences sector, which encompasses pharmaceuticals, biotechnology, and medical devices. Capitalizing on BlackRock's extensive industry knowledge, BMEZ targets significant growth opportunities driven by demographic shifts and increasing healthcare spending. With its disciplined investment approach and commitment to funding innovative healthcare solutions, BMEZ provides institutional investors a compelling avenue for portfolio enhancement in a dynamic and rapidly evolving market landscape.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)0
Gross Profit (TTM)0
EBITDA
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Revenue/Share (TTM)$0.00
Book Value
Price-to-Book0.90
Price-to-Sales (TTM)9.45
EV/Revenue9.45
EV/EBITDA
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$62.50M
Float0
% Insiders0.00%
% Institutions24.05%

Historical Volatility

HV 10-Day
11.47%
HV 20-Day
12.96%
HV 30-Day
11.96%
HV 60-Day
14.16%
HV Rank
6.7%

Volatility is currently contracting

Latest News

BMEZ: Removal Of Options Should Improve Performance (Rating Upgrade)

BlackRock Health Sciences Trust II offers exposure to healthcare innovation but faces NAV instability and dividend sustainability concerns. BMEZ's strategy targets high-growth healthcare sectors, leveraging BlackRock's expertise, yet recent performance highlights volatility and risk to distributions. Potential growth in healthcare is supported by industry trends, but BMEZ's NAV fluctuations and payout risks warrant close monitoring.

Seeking Alpha5/28/2026Neutral

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BMEZ and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More FINANCIAL SERVICES Stocks

Data last updated: 7/29/2026